Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India

References

• Timeline of WHO’s response to COVID-19 [Internet]. [accessed Aug 5]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline .
   Google Scholar
• WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. [ accessed 2021 Sep 20]. https://covid19.who.int/
   Google Scholar
• COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. [accessed 2021 Aug 3]. https://coronavirus.jhu.edu/map.html .
   Google Scholar
• MoHFW | home [Internet]. Ministry of Health & Family Welfare Government of India; 2021 [accessed 2021 Dec 2]. https://www.mohfw.gov.in/ .
   Google Scholar
• Mondal S, Ghosh S. Mapping First to Second wave transition of covid19 Indian data via Sigmoid function and prediction of Third wave. medRxiv [Internet]. 2021 Jan 1. http://medrxiv.org/content/early/2021/07/14/2021.07.11.21260325.abstract .
   Google Scholar
• Mahase E. Covid-19: what new variants are emerging and how are they being investigated? BMJ [Internet]. 2021 Jan;372:n158: https://www.bmj.com/content/bmj/372/bmj.n158.full.pdf .
   PubMedGoogle Scholar
• WHO Says Indian COVID Strain ‘a Variant of Concern’ [Internet]. 2021 [accessed 2021 Aug 2]: https://www.webmd.com/lung/news/20210510/who-says-indian-covid-strain-a-variant-of-concern
   Google Scholar
• Noorimotlagh Z, Jaafarzadeh N, Martínez SS, Mirzaee SA. A systematic review of possible airborne transmission of the COVID-19 virus (SARS-CoV-2) in the indoor air environment. Environ Res [Internet]. 2021 Feb;193:110612. doi:10.1016/j.envres.2020.110612 .
   PubMed Web of Science ®Google Scholar
• Greenhalgh T, Jimenez JL, Prather KA, Tufekci Z, Fisman D, Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021 May;397(10285):1603–7. http://www.thelancet.com/article/S0140673621008692/fulltext .
   PubMed Web of Science ®Google Scholar
• Siemieniuk RAC, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Kum E, Pardo-Hernandez H, Qasim A, Martinez JP, Rochwerg B, et al. Drug treatments for covid-19: living systematic review and network meta-Analysis. BMJ. 2020 Jul;370:1–18.
   Google Scholar
• WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results. N Engl J Med. 2021 Feb;384(6):497–511. doi:10.1056/NEJMoa2023184 .
   PubMed Web of Science ®Google Scholar
• Kashte S, Gulbake A, El-Amin SF III, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell. 2021 May;34(3):711. doi:10.1007/s13577-021-00512-4 .
   PubMed Web of Science ®Google Scholar
• Kim YC, Dema B, Reyes-Sandoval A. COVID-19 vaccines: breaking record times to first-in-human trials. Npj Vaccines. 2020 Apr;5(1):1–3. doi:10.1038/s41541-020-0188-3 .
   PubMed Web of Science ®Google Scholar
• COVAXIN - India’s First Indigenous Covid-19 Vaccine | bharat Biotech [Internet]. 2021 [accessed 2021 Aug 1]. https://www.bharatbiotech.com/covaxin.html .
   Google Scholar
• COWIN. Largest Vaccination Drive. [Internet]. Ministry of Health & Family Welfare Government of India. [accessed Dec 2]. https://www.cowin.gov.in/home .
   Google Scholar
• Press Information Bureau. Phase 3 Clinical Trial of COVAXIN, developed by ICMR & Bharat Biotech, shows 81% efficacy [Internet]. Press Information Bureau. 2021 [accessed 2022 May 1]. https://www.bharatbiotech.com/images/press/covaxin-phase3-clinical-trials-interim-results.pdf .
   Google Scholar
• Sapkal GN, Yadav PD, Ella R, Deshpande GR, Sahay RR, Gupta N, Vadrevu K M, Abraham P, Panda S, Bhargava B. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun;28(4):1–3.
   Web of Science ®Google Scholar
• Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room. Lancet Microbe. 2021;2(7):e279–e280. doi:10.1016/S2666-5247(21)00069-0 .
   PubMedGoogle Scholar
• Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW. Pollard A j. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2021 Feb;21(2):e26–35. doi:10.1016/S1473-3099(20)30773-8 .
   PubMed Web of Science ®Google Scholar
• World Health Organization. Evaluation of COVID-19 vaccine effectiveness. Geneva: World Health Organization. [Internet]. Vol. 70. 2021 [accessed 2021 May 15]. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1 .
   Google Scholar
• Sample size calculator for evaluation of COVID-19 vaccine effectiveness (Excel) [Internet]. [accessed 2021 Aug 5]: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccine_effectiveness-measurement_tool-2021.1 .
   Google Scholar
• Clinical Guidance for Management of Adult COVID-19 Patients | AIIMS Covid Information Portal [Internet]. 2021 [accessed 2021 Aug 5]. https://covid.aiims.edu/clinical-guidance-for-management-of-adult-covid-19-patients/ .
   Google Scholar
• Centre for Disease Control. COVID-19 Vaccine Breakthrough Infections Reported to CDC. Morb Mortal Wkly Rep. 2021;70(21):792–93.
   PubMed Web of Science ®Google Scholar
• Indian Council of Medical Research. Strategy for COVID-19 testing in India [Internet]. Vol. Version 5, National Task Force on COVID-19. 2020. https://www.mohfw.gov.in/pdf/AdvisoryonstrategyforCOVID19TestinginIndia.pdf .
   Google Scholar
• Vaccines and immunization [Internet]. [accessed 2021 Aug 5]. https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1 .
   Google Scholar
• Basics of Vaccines | CDC [Internet]. [accessed 2021 Aug 5]. https://www.cdc.gov/vaccines/vpd/vpd-vac-basics.html .
   Google Scholar
• Coronavirus disease (COVID-19): vaccines [Internet]. [accessed 2021 Aug 5]. https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines
   Google Scholar
• Bhattacharya A, Ranjan P, Ghosh T, Agarwal H, Seth S, Maher GT, Upadhyay AD, Kumar A, Baitha U, Gupta G, et al. Evaluation of the dose-effect association between the number of doses and duration since the last dose of COVID-19 vaccine, and its efficacy in preventing the disease and reducing disease severity: a single centre, cross-sectional analytical study from In. Diabetes Metab Syndr. 2021;15(5):102238. doi:10.1016/j.dsx.2021.102238 .
   PubMed Web of Science ®Google Scholar
• WHO | SARS-CoV-2 Variants [Internet]. WHO. World Health Organization; 2021 [accessed 2021 Aug 5]. http://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/ .
   Google Scholar
• WHO classifies triple-mutant Covid variant from India as global health risk [Internet]. [accessed 2021 Aug 6]. https://www.cnbc.com/2021/05/10/who-classifies-triple-mutant-covid-variant-from-india-as-global-health-risk-.html .
   Google Scholar
• Adam D. What scientists know about new, fast-spreading coronavirus variants. Nature [Internet]. 2021 May. http://www.nature.com/articles/d41586-021-01390-4 .
   Google Scholar
• Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021 Jan;184(2):476–488.e11. doi:10.1016/j.cell.2020.12.015 .
   PubMed Web of Science ®Google Scholar
• Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 Mar;384(20):1885–98. doi:10.1056/NEJMoa2102214 .
   PubMed Web of Science ®Google Scholar
• Callaway E, Mallapaty S. Novavax offers first evidence that COVID vaccines protect people against variants. Nature. 2021 Jan;590(7844):17. doi:10.1038/d41586-021-00268-9 .
   PubMed Web of Science ®Google Scholar
• Yadav PD, Sapkal GN, Ella R, Sahay RR, Nyayanit DA, Patil DY, Deshpande G, Shete AM, Gupta N, Mohan VK, et al. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin. J Travel Med. 2021;28(7):104. doi:10.1093/jtm/taab104 .
   Web of Science ®Google Scholar
• Tyagi K, Ghosh A, Nair D, Dutta K, Bhandari PS, Ansari IA, Misra A. Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India. Diabetes Metab Syndr Clin Res Rev. 2021;15(3):1007–08. doi:10.1016/j.dsx.2021.05.001 .
   PubMedGoogle Scholar
• Hacisuleyman E, Hale C, Saito Y, Blachere NE, Bergh M, Conlon EG, Schaefer-Babajew DJ, DaSilva J, Muecksch F, Gaebler C. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med. 2021;384(23):2212–18. doi:10.1056/NEJMoa2105000 .
   PubMed Web of Science ®Google Scholar
• Farinholt T, Doddapaneni H, Qin X, Menon V, Meng Q, Metcalf G, Chao H, Gingras M-C, Avadhanula V, Farinholt P, et al. Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections. BMC Med. 2021;19(1):255. doi:10.1186/s12916-021-02103-4 .
   PubMed Web of Science ®Google Scholar
• Dash GC, Subhadra S, Turuk J, Parai D, Rath S, Sabat J, Rout UK, Kanungo S, Choudhary HR, Nanda RR, et al . Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN®) and AZD1222 (COVISHIELDTM) recipients: report from the eastern state of India. J Med Virol. 2022;94:1201–1205.
   PubMed Web of Science ®Google Scholar
• Mishra M, Chaudhry R, Rana F, Nag DS, and Rai S. Serosurveillance of health care workers in a COVID hospital: immune response, and its longevity. Cureus. 2021;13(3):e14020.
   PubMed Web of Science ®Google Scholar
• Vitale J, Mumoli N, Clerici P, De Paschale M, Evangelista I, Cei M, Mazzone A. Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy. JAMA Intern Med. 2021; May 28;181(10):1407. doi:10.1001/jamainternmed.2021.2959 .
   PubMedGoogle Scholar
• Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, Brooks N, Smaja M, Mircus G, Pan K. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021 May 15;397(10287):1819–29. doi:10.1016/S0140-6736(21)00947-8 .
   PubMed Web of Science ®Google Scholar
• Bhatnagar T, Chaudhuri S, Ponnaiah M, Yadav PD, Sabarinathan R, Sahay RR, Ahmed F, Aswathy S, Bhardwaj P, Bilimale A, et al. Effectiveness of BBV152/Covaxin and AZD1222/Covishield Vaccines Against Severe COVID-19 and B.1.617.2/Delta Variant in India, 2021: a multi-centric hospital-based case-control study. 2021. doi:10.2139/ssrn.3955739 .
   Google Scholar
• Calzetta L, Ritondo BL, Coppola A, Matera MG, Di Daniele N, Rogliani P. Factors Influencing the Efficacy of COVID-19 Vaccines: a Quantitative Synthesis of Phase III Trials. Vaccines. 2021;9(4):341. Internet pmc/articles/PMC8065664/ .
   Web of Science ®Google Scholar
• Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. Nat Med [Internet]. 2021; July 16:1–2. https://www.nature.com/articles/s41591-021-01459-7 .
   Google Scholar
• Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med [Internet]. 2021;1–10. https://www.nature.com/articles/s41591-021-01454-y .
   Google Scholar
• Switzerland plans to lift quarantine for vaccinated arrivals & those who have recovered from COVID-19 - SchengenVisaInfo.com [Internet]. [accessed 2021 Aug 6]. https://www.schengenvisainfo.com/news/switzerland-plans-to-lift-quarantine-for-vaccinated-arrivals-those-who-have-recovered-from-covid-19/ .
   Google Scholar
• Fully vaccinated Germans to be exempt from quarantine - minister | reuters [Internet]. [accessed 2021 Aug 6]. www.reuters.com/world/europe/fully-vaccinated-germans-be-exempt-quarantine-minister-2021-05-03/
   Google Scholar
• Interim Public Health Recommendations for Fully Vaccinated People | CDC [Internet]. [accessed 2021 Aug 6]. www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html .
   Google Scholar